DHODH and acute myeloid leukemia: In addition, in order to explore new targeting, Wu et al. (Wu et al., 2018) knocked-down of dihydroorotate dehydrogenase by CRISPR/Cas9 technology, which resulted in apoptosis and normal differentiation of acute myeloid leukemia cells.